About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Benign prostatic hypertrophy
Erectile dysfunction
Incontinence
Urinary tract infection
97 library items
in Incontinence
Filter results by:
Date Published
2012 (8)
2011 (14)
2010 (19)
2009 (14)
2008 (7)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Urology (
remove
)
,
Incontinence (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 97
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
|
Next
1.
Phase III data for Onabotulinumtoxin A (Botox®) in neurogenic detrusor overactivity
Source:
J Urology
,
Date published:
15/05/2012
Category:
4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders
|
Incontinence
|
Neurology
NeLM
Area:
News
Link (full access restricted to subscribers)
2.
Clinical review: Management of overactive bladder syndrome
Source:
BMJ
,
Date published:
18/04/2012
Category:
7.4 Drugs for genito-urinary disorders
|
Drug reviews
|
Incontinence
NeLM
Area:
News
link
3.
Horizon scanning: FDA panel favours mirabegron for the treatment of overactive bladder
Source:
PharmaTimes
,
Date published:
10/04/2012
Category:
7.4.2 Drugs for urinary frequency, enuresis, and incontinence
|
Food &Drug Administration (FDA)
|
Incontinence
|
New drugs
NeLM
Area:
News
Link
4.
Phase III trials of BOTOX® (botulinum toxin A) report positive findings for treatment of idiopathic overactive bladder
Source:
BioSpace
,
Date published:
29/03/2012
Category:
4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Food &Drug Administration (FDA)
|
Incontinence
|
Licence extension
NeLM
Area:
News
Link
5.
NHS Choices ‘Behind the Headlines’ assessment of press reports on a study of Botox® for detrusor overactivity
Source:
NHS Choices
,
Date published:
13/03/2012
Category:
4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders
|
Incontinence
|
Information provision
NeLM
Area:
News
Link
6.
NICE issues draft guideline on incontinence in neurological disease
Source:
NICE
,
Date published:
08/03/2012
Category:
Clinical guidelines
|
Incontinence
|
National Institute of Clinical Excellence (NICE)
|
Neurology
NeLM
Area:
News
Link
7.
Horizon scanning: Conference data for mirabegron for overactive bladder
Source:
Astellas
,
Date published:
07/03/2012
Category:
7.4.2 Drugs for urinary frequency, enuresis, and incontinence
|
Incontinence
|
New drugs
NeLM
Area:
News
Press release
8.
Horizon scanning: Positive phase II data of solabegron in overactive bladder presented at conference
Source:
BioSpace
,
Date published:
02/03/2012
Category:
7.4.2 Drugs for urinary frequency, enuresis, and incontinence
|
Incontinence
|
New drugs
NeLM
Area:
News
Link
9.
FDA approves Antares’ topical oxybutynin gel for treatment of overactive bladder
Source:
BioSpace
,
Date published:
09/12/2011
Category:
7.4.2 Drugs for urinary frequency, enuresis, and incontinence
|
Food &Drug Administration (FDA)
|
Incontinence
|
New drugs
NeLM
Area:
News
Link
10.
To what extent are national guidelines for the management of urinary incontinence in women adhered? Data from a national audit
Source:
British Journal of Obstetrics and Gynaecology
,
Date published:
30/11/2011
Category:
Incontinence
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
Results 1 - 10 of 97
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
|
Next